Polynovo | PNV - Fremdkapital

Aktienkurs
0.94
Täglich Wechseln
-0.04 -3.59%
Monatlich
4.44%
Jährlich
-11.74%
Q2 Prognose
0.91




Fremdkapital Veränderung Datum
Alcidion AUD 318K 376K 2025-12
Ansell USD 751.6M 113.1M 2025-12
Avita Medical AUD 42.24M 1.25M 2024-12
Cochlear AUD 200M 6.5M 2025-12
CSL USD 10.42B 273M 2025-12
Healius AUD 1.22B 103M 2024-12
Integral Diagnostics AUD 341.63M 1.98M 2024-06
Mayne Pharma AUD 2.66M 153K 2025-06
Nanosonics AUD 3.21M 1.06M 2025-12
Ramsay Health Care AUD 11.2B 5.74B 2025-12
ResMed USD 403.92M 4.74M 2025-12
Sonic Healthcare AUD 4.19B 333.39M 2024-12
Telix Pharmaceuticals AUD 448.45M 76.97M 2025-12